Text-message support for HIV prevention in people who use drugs
Part of Infections clinical trials.
This study tests a text-message program to help people who use drugs learn about and start taking PrEP, a daily pill that prevents HIV. The program sends short messages on your phone to support you in staying HIV-free.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have used drugs in the last 6 months (any kind).
- You are HIV-negative or don't know your HIV status.
- You are not currently taking PrEP (HIV prevention pills).
- You have a personal phone that can get Telegram or WhatsApp messages.
- You can agree to take part in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether daily text messages can help reduce drinking and lower HIV risk. It is for men who have sex with men and who drink heavily, and uses simple text check-ins to support healthier choices.
This study tests how to better support HIV prevention for people who inject drugs and are newly starting PrEP (medicine to prevent HIV). It focuses on people taking medication for opioid use disorder and who have mild thinking and memory problems, to help them stay safe and adhere to prevention.
This study tests a smartphone program to help HIV-negative men who have sex with men reduce meth use and improve PrEP adherence. It explores whether combining support for both behaviors is more effective than addressing them separately.
This study helps young people who are at risk for HIV get on PrEP—a daily pill or shot that prevents HIV. It tests different ways to help you start and stay on PrEP, with care available at clinics or in your community.
This trial tests whether phone-based (iPhone/Android) text-message support can improve how consistently people use PrEP, an HIV prevention medicine. It may help you stay on track with refills and clinic visits, especially if you’re at higher risk of stopping PrEP.
This study tests different ways to help people who inject drugs stay on PrEP, a daily pill that prevents HIV. It's for people who are HIV-negative and have recently injected drugs.
Hear when a new Drug Use trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.